REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) Ireland - English - HPRA (Health Products Regulatory Authority)

repevax, suspension for injection, in pre-filled syringe diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

sanofi pasteur - tetanus toxoid; diphtheria toxoid; pertussis toxoid; filamentous haemagglutinin (fha); pertactin; polio virus type 1 inactivated; polio virus type 2 inactivated; polio virus type 3 inactivated; adsorbed aluminium phosphate; adsorbed fimbriae types 2 + 3 - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-pertussis-poliomyelitis-tetanus

Repevax vaccine suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

repevax vaccine suspension for injection 0.5ml pre-filled syringes

sanofi - tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; human poliovirus type 3 inactivated; diphtheria toxoid - suspension for injection

Adacel Suspension for Injection in pre-filled syringe Malta - English - Medicines Authority

adacel suspension for injection in pre-filled syringe

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - tetanus toxoid, diphtheria toxoid, pertussis toxoid, filamentous haemagglutinin, fha, pertactin, fimbriae types, and, aluminium phosphate - suspension for injection in pre-filled syringe - aluminium phosphate 1.5 mg tetanus toxoid 20 iu diphtheria toxoid 2 iu pertussis toxoid 2.5 µg filamentous haemagglutinin (fha) 5 µg pertactin 3 µg fimbriae types 2 and 3 5 µg - vaccines

DT Vaccine New Zealand - English - Medsafe (Medicines Safety Authority)

dt vaccine

sanofi-aventis new zealand limited - diphtheria toxoid, adsorbed 100 iu/ml; tetanus toxoid, adsorbed 100 iu/ml - solution for injection - active: diphtheria toxoid, adsorbed 100 iu/ml tetanus toxoid, adsorbed 100 iu/ml excipient: aluminium hydroxide sodium chloride sodium timerfonate water for injection

BOOSTRIX VACCINE Singapore - English - HSA (Health Sciences Authority)

boostrix vaccine

glaxosmithkline pte ltd - diphtheria toxoid; filamentous haemagglutinin; pertactin; pertussis toxoid; tetanus toxoid - injection - 2 iu/0.5 ml - diphtheria toxoid 2 iu/0.5 ml; filamentous haemagglutinin 8 mcg/0.5 ml; pertactin 2.5 mcg/0.5 ml; pertussis toxoid 8 mcg/0.5 ml; tetanus toxoid 20 iu/0.5 ml

BOOSTRIX 0.5 mL injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

boostrix 0.5 ml injection pre-filled syringe

glaxosmithkline australia pty ltd - pertussis toxoid, quantity: 16 microgram/ml; pertussis filamentous haemagglutinin, quantity: 16 microgram/ml; pertactin, quantity: 5 microgram/ml; diphtheria toxoid, quantity: 4 iu/ml; tetanus toxoid, quantity: 40 iu/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; aluminium phosphate; sodium chloride; water for injections - boostrix is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals aged four years and older (see section 4.2 dose and method of administration).,boostrix is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy (see section 4.2 dose and method of administration, section 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties).,the use of boostrix should be in accordance with official recommendations.

BOOSTRIX 0.5 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

boostrix 0.5 ml injection vial

glaxosmithkline australia pty ltd - pertussis toxoid, quantity: 16 microgram/ml; tetanus toxoid, quantity: 40 iu/ml; diphtheria toxoid, quantity: 4 iu/ml; pertactin, quantity: 5 microgram/ml; pertussis filamentous haemagglutinin, quantity: 16 microgram/ml - injection, suspension - excipient ingredients: water for injections; aluminium hydroxide hydrate; aluminium phosphate; sodium chloride - boostrix is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals aged four years and older (see section 4.2 dose and method of administration).,boostrix is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy (see section 4.2 dose and method of administration, section 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties).,the use of boostrix should be in accordance with official recommendations.

Infanrix-IPV vaccine suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

infanrix-ipv vaccine suspension for injection 0.5ml pre-filled syringes

glaxosmithkline uk ltd - diphtheria toxoid; tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; human poliovirus type 3 inactivated - suspension for injection

Infanrix-IPV + Hib vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

infanrix-ipv + hib vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes

glaxosmithkline uk ltd - diphtheria toxoid; tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; human poliovirus type 3 inactivated; haemophilus influenzae type b polysaccharide protein conjugate - powder and suspension for suspension for injection

ADT Booster New Zealand - English - Medsafe (Medicines Safety Authority)

adt booster

seqirus (nz) ltd - diphtheria toxoid, adsorbed 2 [iu] (not less than 2iu/0.5ml); tetanus toxoid, adsorbed 20 [iu] (not less than 20iu/0.5ml) - suspension for injection - 2iu/20iu - active: diphtheria toxoid, adsorbed 2 [iu] (not less than 2iu/0.5ml) tetanus toxoid, adsorbed 20 [iu] (not less than 20iu/0.5ml) excipient: aluminium hydroxide sodium chloride sodium hydroxide water for injection - vaccination of children (not less than 5 years of age) and adults who have previously received at least 3 doses of a vaccine for primary immunisation against diphtheria and tetanus. adt booster is not intended for primary immunisation against diphtheria and tetanus.